LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

Search

Avita Therapeutics Inc

Geschlossen

4.36 1.87

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.36

Max

4.36

Schlüsselkennzahlen

By Trading Economics

Einkommen

1.6M

-12M

Verkäufe

554K

18M

EPS

-0.536

Gewinnspanne

-65.968

Angestellte

226

EBITDA

1.6M

-9.7M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

-6.05% downside

Dividenden

By Dow Jones

Nächstes Ergebnis

7. Mai 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

3.9M

127M

Vorheriger Eröffnungskurs

2.49

Vorheriger Schlusskurs

4.36

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

Avita Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Feb. 2026, 23:55 UTC

Market Talk

Gold and Silver Rise Amid Renewed Trade Tensions -- Market Talk

22. Feb. 2026, 23:53 UTC

Market Talk

Japan Activity Data Set to Show Strength, Backed by Fiscal Spending -- Market Talk

22. Feb. 2026, 23:53 UTC

Market Talk

Key China Rates Likely to Be Held Steady for Now -- Market Talk

22. Feb. 2026, 23:51 UTC

Market Talk

Bank of Korea Set to Hold Fire as Inflation Steadies, Risks Linger -- Market Talk

22. Feb. 2026, 23:35 UTC

Market Talk

Oil Falls Amid Prospect That U.S. Strike on Iran Might Be Limited -- Market Talk

22. Feb. 2026, 23:21 UTC

Ergebnisse

Nickel Industries 2025 Adjusted Ebitda US$283.0 Million

22. Feb. 2026, 23:20 UTC

Ergebnisse

Nickel Industries 2025 Operating Profit US$126.4 Million

22. Feb. 2026, 23:19 UTC

Ergebnisse

Nickel Industries 2025 Revenue US$1.65 Billion, Down 5.5% On-Year

22. Feb. 2026, 23:19 UTC

Ergebnisse

Correct: Nickel Industries 2025 Net Loss US$57.1 Million, Down 66% On-Year

22. Feb. 2026, 23:18 UTC

Ergebnisse

Nickel Industries Won't Pay a Final Dividend

22. Feb. 2026, 23:16 UTC

Ergebnisse

Nickel Industries 2025 Net Loss A$57.1 Million, Down 66% On-Year

22. Feb. 2026, 21:35 UTC

Ergebnisse

Ampol Expects to Start Commissioning of Ultra Low Sulfur Fuels Project in 2Q

22. Feb. 2026, 21:34 UTC

Ergebnisse

Ampol Says F&I Australia, International Have Begun 2026 Strongly

22. Feb. 2026, 21:34 UTC

Ergebnisse

Ampol Expects Stage 1 of Fuel Security Services Payment Review Finalized in 1Q

22. Feb. 2026, 21:33 UTC

Ergebnisse

Ampol Says Lytton Refiner Margin Was US$8.13/bbl in January

22. Feb. 2026, 21:33 UTC

Ergebnisse

Ampol Recognizes A$89.9 Million Impairment in Carrying Value of Investment in Seaoil

22. Feb. 2026, 21:28 UTC

Ergebnisse

Ampol Final Dividend A$0.60/Share

22. Feb. 2026, 21:28 UTC

Ergebnisse

Ampol FY Revenue A$31.37 Billion, Down 10%

22. Feb. 2026, 21:28 UTC

Ergebnisse

Ampol FY Replacement-Cost Net Profit A$429.2 Million, Up 83%

22. Feb. 2026, 21:28 UTC

Ergebnisse

Ampol FY Historical-Cost Net Profit A$82.4 Million, Down 33%

21. Feb. 2026, 14:31 UTC

Akquisitionen, Fusionen, Übernahmen

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

21. Feb. 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

20. Feb. 2026, 23:12 UTC

Akquisitionen, Fusionen, Übernahmen

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20. Feb. 2026, 22:12 UTC

Ergebnisse

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

20. Feb. 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

20. Feb. 2026, 21:23 UTC

Ergebnisse

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20. Feb. 2026, 21:20 UTC

Market Talk

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20. Feb. 2026, 21:01 UTC

Akquisitionen, Fusionen, Übernahmen

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20. Feb. 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

Peer-Vergleich

Kursveränderung

Avita Therapeutics Inc Prognose

Kursziel

By TipRanks

-6.05% Nachteil

12-Monats-Prognose

Durchschnitt 4.5 USD  -6.05%

Hoch 5.5 USD

Tief 3.5 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avita Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

1

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

8.83 / 9.77Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Weak Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
help-icon Live chat